Clinical applications of recombinant human growth hormone in adults

Expert Opinion on Pharmacotherapy

Volumn 1, Issue 1, 1999, Pages 97-107

  Iglesias, P ^a   Diez J J ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

Adults; Clinical applications; Growth hormone; Growth hormone therapy; Physiological actions

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADULT; CLINICAL TRIAL; HUMAN; PHYSIOLOGY; REVIEW;

ADULT; CLINICAL TRIALS; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS;

EID: 0033224492     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.1.1.97     Document Type: Article

References (52)

1. GROWTH HORMONE RESEARCH SOCIETY: Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society workshop on adult growth hormone deficiency. J. Clln. Enclocrinol. Metab. (1998) 48:109-115. Present recommendations on the diagnosis and treatment of adult GHD syndrome.
2. CORCORAN C, GRINSI'OON S: Treatments for wasting in patients with the acquired immunodeficiency syndrome. Keu'Engl.J. Met!. (1999) 340:1740-1750. Excellent review of anabolic treatments for patients with AIDS wasting.
3. WALLYMAHMED ME, FOY P, SHAW D, HUTCHEON R, EDWARDS RH, MACFARLANE IA: Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin. Emlucrinol. (1997) 47-A39-446. • Prospective study of rhGH replacement therapy in adult GHD.
4. JOHANNSSON G, GRIMBY G, SUNNERHAGEN KS, BENGTSSON BA: Two years of growth hormone (GH) treatment increase isometric and isokinctic muscle strength in GH-deficient adults. J Clin. Enclocrinol. Mctab. (1997) 82:2877-2884.
5. SHALET SM, TOOGOOD A, RAHIM A, BRENNAN BM: The diagnosis of growth hormone deficiency in children and adults. Emlocr. Rei>. (1998) 19:203-223. A thorough review of clinical and biochemical approaches to the diagnosis of GHD syndrome.
6. MANSON JMCK, WILMORE DW: Positive nitrogen balance with human -growth hormone and hypocaloric intravenous feeding. Stirgerj' (1986) 100:188-197.
7. CARROLL PV, CHRIST ER, BENGTSSON BA et al.: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin. Emlocrinol. Metab. (1998) 83:382-395. An excellent review of GHD in adults and the effects of GH replacement.
8. RUSSELL-JONES DL, BOWES SB, REES SE et til.: Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults. Am. J. Pbyslol. (1998) 274:E1050-1056. A randomised study of anabolic effect of GH, body composition and protein metabolism in GHD adults.
9. JENSEN MB, KISSMEYER NIELSEN P, LAURBERG S: Perioperative growth hormone treatment increases nitrogen and fluid balance and results in short-term and long-term conservation of lean tissue mass. Am. J. Clin. Nutr. (1998) 68:810-846.
10. AL SHOUMER KA, GRAY R, ANYAOKU V et al.: Effects of four years' treatment with biosynthctic human growth hormone (GH) on glucose homeostasis, insulin secretion and lip id metabolism in GH deficient adults. Clin. Endocrinol. (1998) 48:795-802.
11. ISESHYAH SA, JOHNSTON DG: Cardiovascular disease and risk factors in adults with hypopituitarism. Clin. Emlocrinol. (1999) 50:1-15. A recent review of epidemiological and experimental data on cardiovascular morbidity and mortality in adult hypopituitarism.
12. OHLSSON C, BENGTSSON B, 1SAKSSON OGP, ANDREASSEN TT, SLOOTWEG MC: Growth hormone and bone. Einlocr. Kei: (1998) 19:55-79. A thorough review of the effects of GH on bone both in animals and humans.
13. ROSEN T, W1LHELMSEN L, LANDIN-WILHELMSEN K, LAPl'AS G, BENGTSSON BA: Increased fracture frequency hi adult patients with hypopituitarism and GH deficiency. Enr.J. Emlocrinol. (1997) 137:240-245. • Comparative study of fracture rate in patients with adultonset GHD.
14. RAHIM A, HOLMES SJ, ADAMS JE, SHALET SM: Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Clin. Emlocrinol. (1998) 48(4):463-469. • Evaluation of long-term impact on BMD after a short course of GH replacement in GHD adults.
15. CUOCOLO A, NICOLAI E, COLAO A et al.: Improved left ventricular function after growth hormone replacement in patients with hypopituitarism; assessment with radionuclidc angiography. Enr.J. A7:J. Meet. (1996) 23:390-394.
16. DÜNNE FP, ELLIOT P, GAMMOGE MD et ah. Cardiovascular function and gliicocorticoid replacement in patients with hypopituitarism. Clin. Endocrinol. (1995) 43:623-629.
17. MOLLER J, JORGENSEN JO, MOLLER N, CHR1STIANSENJS, WEEKE J: Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism (1992) 41:728-731.
18. JORGENSEN JO, MOLLER J, SKAKKEBAEK NE, WEEKE J, CHR1STIANSEN JS: Thyroid function during growth hormone therapy. Honn. Res. (1992) 38(Suppl. 1):63-67.
19. FELD S, HIRSCHBERG R: Growth hormone, the insulinlikc growth factor system, and the kidney. Enclocr. Rev. (1996) 17:423-480. An excellent review of GH and the kidney.
20. JENKINS RC, ROSS RJM: Growth hormone therapy for protein catabolism. Quart. J. Mecl. (1996) 89:813-819. A detailed review of GH therapy in the catabolic patient.
21. TRITOS NA, MANTZOROS CS: Rccombinant human growth hormone: old and novel uses. Am.J. Med. (1998) 105:44-57. A thorough review of paediatric and adult uses of rhGH.
22. CUNEO RC, JUDD S, WALLACE JD et al.: The Australian multiccntcr trial of growth hormone (GH) treatment in Gil-deficient adults. J Clin. Eiulocrinol. Metab. (1998) 83:107-116. Results of an Australian multicentre, randomised, doubleblind, placebo-controlled trial of the effects of rhGH in adults with GHD.
23. DE BOER H, VAN DER VEEN E: Guidelines for optimizing growth hormone replacement therapy in adults. Horm. Res. (1997) 48(Suppl. 5):21-30. • Review of rhGH replacement therapy in adults with GHD.
24. MULLIGAN K, GRUNFELD C. HELLERSTEIN MK, NEESE RA. SCHAMBELAN M: Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection.J Clin. Endücrinul. Metab. (1993) 77:956-962.
25. KRENTZ AJ, KOSTER FT, CRIST DM et al.: Anthropometrie, metabolic, and immunological effects of rccombinant human growth hormone in AIDS and AlDS-related complex.J Acquit: Immune. Defic. Syiulr. (1993)6:245-251.
26. SCHAMBELAN M, MULLIGAN K, GRUNFELD C et al.-. Rccombinant human growth hormone in patients with HlV-associatcd wasting. A randomized, placebocontrolled trial. Ann. Intern. Mecl. (1996) 125:873-882.
27. MULLIGAN K, TAI VW, SCHAMBELAN M: Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting. A clinical research center study.J Clin. Enclocrinol. Metab. (1998) 83:1542-1547. • Evaluation of the effects of chronic rhGH treatment on components of energy balance in HIV-associated wasting.
28. WATERS D, DANSKA J, HARDY K et ell.: Rccombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. (1996) 125:865-872.
29. IKIZLER TA, WINGARD RL, HAKIM RM: Interventions to treat malnutrition in dialysis patients: The role of the dose of dialysis, intradialytic parcntcral nutrition, and growth hormone. Am.J. Kidney Dis. (1995) 26:256-265. • Review of interventions to prevent or to treat malnutrition in dialysis patients.
30. ZIEGLER TR, LAZARUS JM, YOUNG LS, HAKIM R, WILMORE DW: Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis.J Am. Soc. Nepbrol. (1991) 2:1130-1135. • The first pilot study of anabolic responses to rhGH in haemodialysis patients.
31. KOPPLE JD: The rationale for the use of growth hormone or insulin-like growth Factor I in adult patients with renal failure. .Miner. Electrolyte Metab. (1992) 18:269-275.
32. IKIZLER AT, WINGARD RL, I3REYER JA, SCHULMAN G, PARKER RA, HAKIM RM: Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int. (1994) 46:1178-1183. • Prospective study of rhGH therapy in CAPD patients.
33. SANAKA T, SUGINO N: Improvement of malnutrition indices in adult patients with end stage renal disease by recombinant human growth hormone. Xipfion fiiszo Gnkkai Sbi (1991) 33:1153-1159.
34. SCHULMAN G, WINGARD RL, HUTCHINSON KL, LAWRENCE P, HAKIM RM: The effects of recombinant human hormone and intradialytic parcntcral nutrition in malnourished hcmodialysis patients. Am. J. Kidney Dis. (1993) 21:527-5)4. Study of the effect of combined rliGH therapy and intradinlytic parenteral nutrition in liaemodialysis patients.
35. IGLESIAS P, DI'EZ JJ, FEUNANDEZ-REYES MJ et al.: Rccombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study. Am.J. Kidney Dis. (1998) 32:454-463. • First randomised, controlled study of rhGH therapy in dialysis (CAPD and HD) patients.
36. TAJEK JA, BRASSELJA: Failure of anaboUsm in malnourished cancer patients receiving growth hormone. A clinical research center study. J. Clin. Endocrinol. MeUib. (1995) 80:2082-2087.
37. SUCHNEK U, ROTHKOPF MM, STANISLAUS G, ELWYN DH, KVETAN V, ASKANAZI J: Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. Arch. Intern. Meet. (1990) 150:1225-1230.
38. PAPE GS, FRIEDMANM, UNDERWOOD L, CLEMMONS DR: The effect of GH on weight gain and pulmonary function in patients with chronic obstructive lung disease. ObesJ(1991) 99:1495-1500.
39. DOUGLAS RG, HUMBERSTONE DA, HAYSTEAD A, SHAW JHF: Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parcntcral nutrition. Br.J. Stirg. (1990) 77:785-790.
40. VOERMAN HJ, STRACK VAN SCHIJNDEL RJ, GROENEVELD All et al.: Effects of recombinant human growth hormone in patients with severe sepsis. Ann. Surg. (1992) 216:648-655-
41. JEEVANANDAM M, ALI MR, HOLADAY NJ, PETERSEN SR: Adjuvant rccombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. J. Parenter. Enterai i\'ntr. (1995) 19:137-144.
42. KNOX J, DEMLING R, WILMORE D, SAKRAF P, SANTOS A: Increased survival after major thermal injury: the effect of growth hormone therapy in adults.J Trauma (1995) 39:526-530. • Evaluation of safety ad efficacy of rliGH administration in a high-risk population of burned patients.
43. ZIEGLER TR, YOUNG LS, MANSON JMCK, WILMORE DW: Metabolic effects of rccombinant human growth hormone in patients receiving parenteral nutrition. Ann. Snrg. (1988) 208:6-16. • Study of combined rliGH administration and total parenteral nutrition in postoperative patients.
44. TAGLIAFERRI M, SCACCHI M, PINCELLI AI et al.: Metabolic effects of biosynthctic growth hormone treatment in severely energy-restricted obese women. Int. J. Obes. Relat. Metab. Disorcl. (1998) 22:836-841.
45. RUDMAN D, FELLER AG, NAGRAJ HS et al.: Effects of human growth hormone in men over 60 years old. Netf Engl. J. Med. (1990) 323:1-6.
46. WAGGØ H: Local treatment of ulcers in diabetic foot with human growth hormone. Lancet (1987.) 1:1485.
47. SALCEDO I, SERRA Mb, MARQUES AI', MENDOÇA M, SERRA L: Growth hormone solution applied directly to diabetic foot ulcers. Preliminary results. In: Recent Advances on Growth and Growth Hormone Therapy (Volume 2). Saggese G, Stanhope R (Eds.), Freund Publishing House Ltd., London, UK (1995):223-237.
48. GENAZZANI AD, PETRAGLIA F, VOLPOGNI C et al.: Growth hormone treatment affects plasma LH pulsatile release in women with secondary amcnorrhoea. Clin. Enilocrinol. (1993) 39:607-611.
49. OVENSEN PG, JORGENSEN Jb, INGERSLEV J, ORSKOV H, CHRISTIANSEN JS: Growth hormone treatment of men with reduced sperm quality. Ugeskr. Laeger (1998) 160:176-180.
50. VERHELST L, AUS R, VANDEWEDGHE M et cl!.: Two years of replacement therapy in adults with growth hormone deficiency. Clin.Eiulocrinol.W)!) 47:485-494. Study of a large group of adult GHD patients treated with rhGH for two years.
51. TAKAL J, RUOKONEN E, WEBSTER NR et al.: Increased mortality associated with growth hormone treatment in critically ill adults. Kew Engl. J. Metl. (1999) 341:785-792.
52. CJMaria Sevilla Diago, 9, 3CJ dcha, 28022, Madrid, Spain